Literature DB >> 25724798

Prevalence of Brucella antibodies on a previously acute brucellosis infected population: sensitivity, specificity and predictive values of Rose Bengal and Wright standard tube agglutination tests.

Panagiotis Andriopoulos1, Antonia Kalogerakou, Dimitra Rebelou, Andrea Paola Rojas Gil, Sofia Zyga, Vassiliki Gennimata, Maria Tsironi.   

Abstract

PURPOSE: Brucellosis is a zoonosis with worldwide distribution. The presence of antibodies after acute infection and the prevalence of positive serology in endemic area are not well documented.
METHODS: Patients hospitalized with acute brucellosis were relocated 3-13 years after the initial infection. Hospital records of the initial infection were retrieved, and examination of Brucella antibodies using Rose Bengal test (RBT) and Wright standard tube agglutination (STA) test was performed.
RESULTS: Eighty-three patients were hospitalized from 2000 to 2010; 50.6 % were farmers and 37.4 % livestock farmers. All had febrile illness and various focal complications. All had positive serology, and 82.2 % had positive blood cultures; 91.5 % were treated with streptomycin plus doxycycline. Seventy-two (86.7 %) were relocated on follow-up. Nine (12.5 %) had positive RBT and STA up to 1/320. Occupational history was associated with positive serology (p = 0.0172), and 8/9 of the positive individuals were livestock farmers (38.0 % of the livestock farmers checked). Residence, years after the infection, clinical presentation of brucellosis and treatment were not associated with serology results. Both tests had excellent sensitivity (nearly 100 %), specificity 87.5 % and excellent negative predictive value (nearly 100 %); however, positive predictive value was only 11.4 %.
CONCLUSIONS: Rapid and low-cost tests as RBT and STA are still very useful in diagnosing acute brucellosis; however, every positive test must be examined together with clinical symptoms and occupational history. The tests can be used as screening tests in endemic populations to rule out acute brucellosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25724798     DOI: 10.1007/s15010-015-0748-z

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  35 in total

Review 1.  Update on laboratory diagnosis of human brucellosis.

Authors:  George F Araj
Journal:  Int J Antimicrob Agents       Date:  2010-08-09       Impact factor: 5.283

2.  A complication of brucellosis: epididymoorchitis.

Authors:  Esragül Akinci; Hürrem Bodur; Mustafa Aydin Cevik; Ayşe Erbay; Selim Sirri Eren; Ipek Ziraman; Neriman Balaban; Ali Atan; Gülüşan Ergül
Journal:  Int J Infect Dis       Date:  2005-12-19       Impact factor: 3.623

Review 3.  Clinical presentations and diagnosis of brucellosis.

Authors:  Aysegul Ulu-Kilic; Gökhan Metan; Emine Alp
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-04

4.  Osteoarthricular involvement of brucellosis in Turkey.

Authors:  Y Taşova; N Saltoğlu; G Sahin; H S Aksu
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

5.  Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.

Authors:  Bosilkovski Mile; Kirova Valerija; Grozdanovski Krsto; Vidinic Ivan; Demiri Ilir; Labacevski Nikola
Journal:  Trop Doct       Date:  2012-01       Impact factor: 0.731

6.  Acute brucellosis: presentation, diagnosis, and treatment of 144 cases.

Authors:  Panos Andriopoulos; Maria Tsironi; Spiros Deftereos; Athanassios Aessopos; Giorgos Assimakopoulos
Journal:  Int J Infect Dis       Date:  2006-05-02       Impact factor: 3.623

7.  A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.

Authors:  Fariba Keramat; Mitra Ranjbar; Mojgan Mamani; Seyyed Hamid Hashemi; Fatemeh Zeraati
Journal:  Trop Doct       Date:  2009-10       Impact factor: 0.731

8.  Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis.

Authors:  Mohammad Reza Hasanjani Roushan; Mohammad Jafar Soleimani Amiri; Abolghasem Laly; Amrollah Mostafazadeh; A Bijani
Journal:  Int J Infect Dis       Date:  2009-08-03       Impact factor: 3.623

Review 9.  Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials.

Authors:  Keren Skalsky; Dafna Yahav; Jihad Bishara; Silvio Pitlik; Leonard Leibovici; Mical Paul
Journal:  BMJ       Date:  2008-03-05

10.  Microangiopathic Anemia of Acute Brucellosis - is it a True TTP?

Authors:  Amir A Kuperman; Amjad Baidousi; Maher Nasser; Andre Braester; Faris Nassar
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-10-02       Impact factor: 2.576

View more
  5 in total

1.  Seroprevalence and risk factors associated with Brucella seropositivity in dairy and mixed cattle herds from Ecuador.

Authors:  A Carbonero; L T Guzmán; I García-Bocanegra; C Borge; L Adaszek; A Arenas; L R Saa
Journal:  Trop Anim Health Prod       Date:  2017-09-26       Impact factor: 1.559

2.  Evaluation of serological diagnostic tests of human brucellosis for prevention and control in Mexico.

Authors:  Carmen Guzmán-Bracho; Berenice Salgado-Jiménez; Liz G Beltrán-Parra; Irma Hernández-Monroy; Fernando Vargas-Pino; Demetrio Rodríguez; Irma López-Martínez; Sergio Pastén-Sánchez; Jesús F González-Roldán; Jorge Membrillo-Hernández; José Alberto Díaz-Quiñónez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-20       Impact factor: 3.267

3.  Brucellosis as a neglected disease in a neglected population: a seroepidemiological study of migratory nomads in the Fars province of Iran.

Authors:  B Honarvar; M Moghadami; K B Lankarani; M A Davarpanah; M Ataolahi; A Farbod; E Eskandari; M Panahi; A Ghorbani; Z Zahiri; R Tabrizi; M Pourjafar; S M M Heidari
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

4.  Performance characteristics and costs of serological tests for brucellosis in a pastoralist community of northern Tanzania.

Authors:  AbdulHamid S Lukambagire; Ângelo J Mendes; Rebecca F Bodenham; John A McGiven; Nestory A Mkenda; Coletha Mathew; Matthew P Rubach; Philoteus Sakasaka; Davis D Shayo; Venance P Maro; Gabriel M Shirima; Kate M Thomas; Christopher J Kasanga; Rudovick R Kazwala; Jo E B Halliday; Blandina T Mmbaga
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

5.  Brucella Seroprevalence in a High-Risk Population in Greece: A Cross-Sectional Study.

Authors:  Panagiotis Andriopoulos; Dimitrios Floros; Natalia Gioti; Anargiros Mariolis; Andrea Paola Rojas Gil; Maria Tsironi
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-12-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.